Search Results - "Oskarsson, P"

Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? by Bragd, J, Adamson, U, Bäcklund, L.B, Lins, P.E, Moberg, E, Oskarsson, P

“…Abstract Aims Is glycaemic variability an independent risk factor for the development of microvascular complications in addition to average glycaemia, as…”
Get full text

Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes by Bjork, E., Berne, C., Kampe, O., Wibell, L., Oskarsson, P., Karlsson, F. A.

“…Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. E Björk , C Berne , O Kämpe , L Wibell , P Oskarsson and…”
Get full text

Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes by BJÖRK, E, BERNE, C, KÄMPE, O, WIBELL, L, OSKARSSON, P, KARLSSON, F. A

“…Twenty islet cell antibody (ICA)-positive patients, aged 19-38 years, with IDDM were randomized at onset to treatment with either diazoxide, a K+ channel…”
Get full text

Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial by Oskarsson, Per, Antuna, Ramiro, Geelhoed-Duijvestijn, Petronella, Krӧger, Jens, Weitgasser, Raimund, Bolinder, Jan

“…Aims/hypothesis Evidence for the effectiveness of interstitial glucose monitoring in individuals with type 1 diabetes using multiple daily injection (MDI)…”
Get full text

A repeated cross-sectional survey of severe hypoglycaemia in 178 Type 1 diabetes mellitus patients performed in 1984 and 1998 by Bragd, J., Adamson, U., Lins, P.-E., Wredling, R., Oskarsson, P.

“…Aims To study the prevalence of severe hypoglycaemia (SH) in relation to risk factors in Type 1 diabetic (T1 DM) patients over a period of 14 years. Methods We…”
Get full text

Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes by Battelino, Tadej, Phillip, Moshe, Bratina, Natasa, Nimri, Revital, Oskarsson, Per, Bolinder, Jan

“…OBJECTIVE: To assess the impact of continuous glucose monitoring on hypoglycemia in people with type 1 diabetes. RESEARCH DESIGN AND METHODS: In this…”
Get full text

Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients by OSKARSSON, P. R, LINS, P. E, BACKMAN, L, ADAMSON, U. C

“…The glycaemic and hormonal responses to a hypoglycaemic event induced by an i.v. bolus of insulin was studied in seven type 1 diabetic patients treated first…”
Get full text

Metabolic and hormonal responses to exercise in type 1 diabetic patients during continuous subcutaneous, as compared to continuous intraperitoneal, insulin infusion by OSKARSSON, P. R, LINS, P. E, HENRIKSSON, H. W, ADAMSON, U. C

“…This study was performed to determine whether metabolic and hormonal responses during moderate exercise differ between continuous intraperitoneal insulin…”
Get full text

Circulating insulin inhibits glucagon secretion induced by arginine in type 1 diabetes by Oskarsson, PR, Lins, PE, Ahre, B, Adamson, UC

“…OBJECTIVE: To evaluate if insulin has a suppressive effect on the glucagon secretion stimulated by arginine in type 1 diabetes. RESEARCH DESIGN AND METHODS:…”
Get full text

Flash glucose monitoring: objective, not self-referential, outcomes are needed. Reply to Warren RE [letter] by Bolinder, Jan, Oskarsson, Per, Antuna, Ramiro, Geelhoed-Duijvestijn, Petronella, Krӧger, Jens, Weitgasser, Raimund

Get full text

Long-term follow-up of insulin-dependent diabetes mellitus patients with recurrent episodes of severe hypoglycaemia by Oskarsson, P., Adamson, U., Clausen Sjöbom, N., Lins, P.-E.

“…We conducted a long-term clinical follow-up of 20 insulin-treated diabetic patients with the problem of repeated severe hypoglycaemic events, identified during…”
Get full text

Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion by Hedman, Christina A., Frystyk, Jan, Lindström, Torbjörn, Oskarsson, Per, Arnqvist, Hans J.

“…Summary Objective Type 1 diabetes (T1D) is associated with low IGF‐I and altered levels of IGF‐binding proteins (IGFBPs) in plasma. This may be of importance…”
Get full text

Effects of C-peptide on insulin-induced hypoglycaemia and its counterregulatory responses in IDDM patients by Oskarsson, P., Johansson, B-L., Adamson, U., Lins, P-E.

“…Recent studies indicate that C‐peptide, when given to patients with insulin‐dependent (Type 1) diabetes mellitus (IDDM), exerts significant effects on…”
Get full text

Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group by Oskarsson, P, Ljunggren, J G, Lins, P E

“…Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group. P Oskarsson , J G Ljunggren and P E Lins…”
Get full text

Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy by Oskarsson, Per, Jan-Gustaf Ljunggren, Per-Eric Lins, The Mexiletine Study Group

“…To investigate the efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. A total of 216 insulin-treated diabetes patients with…”
Get full text

Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial by Bragd, Joakim, von Döbeln, Anna, Lins, Per-Eric, Adamson, Ulf, Bergström, Jakob, Oskarsson, Per

“…It is generally held that basal insulin substitution with continuous subcutaneous insulin infusion (CSII) provides less variable glucose levels than with…”
Get more information

Intraperitoneal insulin delivery gives higher circulating IGF-I activity than CSII in type 1 diabetes by Hedman, CA, Frystyk, J, Lindstrom, T, Oskarsson, P, Arnqvist, HJ

Get full text

Basal Insulin Substitution with Glargine or CSII in Adult Type I Diabetes Patients-A Randomized Controlled Trial by Bragd, J, Adamson, U, Lins, PE, Von Dobeln, A, Oskarsson, P

Get full text

Adverse drug effect as cause of hospital admission. Common drugs are the major part according to the cross-sectional study by Odar-Cederlöf, Ingegerd, Oskarsson, Per, Ohlén, Gunnar, Tesfa, Yohannes, Bergendal, Annica, Helldén, Anders, Bergman, Ulf

Get more information

Efficacy and safe of mexiletine in the treatment of painful diabetic neuropathy by OSKARSSON, P, LJUNGGREN, J.-G, LINS, P.-E

Get full text